Exclusive

Publication

Byline

US Patent Issued to ViiV Healthcare UK (No. 5) on April 7 for "Inhibitors of human immunodeficiency virus replication" (Connecticut Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,276, issued on April 7, was assigned to ViiV Healthcare UK (No. 5) Ltd. (Stevenage, Great Britain). "Inhibitors of human immunodeficiency v... Read More


US Patent Issued to SALK INSTITUTE FOR BIOLOGICAL STUDIES, SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE on April 7 for "Macrocyclic ULK1/2 inhibitors" (California Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,277, issued on April 7, was assigned to SALK INSTITUTE FOR BIOLOGICAL STUDIES (La Jolla, Calif.) and SANFORD BURNHAM PREBYS MEDICAL DISCOVER... Read More


US Patent Issued to CHILDREN'S NATIONAL MEDICAL CENTER on April 7 for "Method for treatment of muscular dystrophy" (Maryland, District Of Columbia Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,278, issued on April 7, was assigned to CHILDREN'S NATIONAL MEDICAL CENTER (Washington). "Method for treatment of muscular dystrophy" was i... Read More


US Patent Issued to SK CHEMICALS, STANDIGM on April 7 for "Composition for preventing or treating TNF-Alpha-related disease, comprising hydroflumethiazide as active ingredient" (South Korean Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,279, issued on April 7, was assigned to SK CHEMICALS Co. LTD. (Seongnam-si, South Korea) and STANDIGM INC. (Seoul, South Korea). "Compositi... Read More


US Patent Issued to UNIVERSITE CLAUDE BERNARD LYON 1, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), HOSPICES CIVILS DE LYON, UNIVERSITE LAVAL on April 7 for "Antiviral compositions for treating the flu" (French, Canadian Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,280, issued on April 7, was assigned to UNIVERSITE CLAUDE BERNARD LYON 1 (Villeurbanne, France), INSTITUT NATIONAL DE LA SANTE ET DE LA RECH... Read More


US Patent Issued to EMALEX BIOSCIENCES on April 7 for "Pharmaceutical dosage forms and methods of use" (American, Canadian Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,281, issued on April 7, was assigned to EMALEX BIOSCIENCES INC. (Chicago). "Pharmaceutical dosage forms and methods of use" was invented by... Read More


US Patent Issued to Guangzhou Cellprotek Pharmaceutical on April 7 for "Use of small molecule compounds in the treatment of diseases mediated by lung epithelial cell injury and/or vascular endothelial cell injury" (Chinese Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,282, issued on April 7, was assigned to Guangzhou Cellprotek Pharmaceutical Co. Ltd. (Guangdong, China). "Use of small molecule compounds i... Read More


US Patent Issued to The Medical College of Wisconsin, Aix-Marseille Universite on April 7 for "Mitochondria-targeted atovagone: a more potent and more effective antitumor, antimicrobial, and antimalarial drug" (American, French Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,283, issued on April 7, was assigned to The Medical College of Wisconsin Inc. (Milwaukee) and Aix-Marseille Universite (Marseilles, France).... Read More


US Patent Issued to PARTHENOGEN SAGL on April 7 for "Combination of micronutrients to stimulate the endogenous production of hydrogen sulfide (H2S)" (Swiss Inventor)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,284, issued on April 7, was assigned to PARTHENOGEN SAGL (Lugano, Switzerland). "Combination of micronutrients to stimulate the endogenous ... Read More


US Patent Issued to APPLIED BIOLOGICAL LABORATORIES on April 7 for "Compositions and methods for protecting against airborne pathogens and irritants" (New York Inventor)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,285, issued on April 7, was assigned to APPLIED BIOLOGICAL LABORATORIES INC. (New York). "Compositions and methods for protecting against a... Read More